Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-wound gentamicin for prevention of surgical site infection after emergent laparotomy
IRCT20260613069779N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Aug 2026
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, single-blind trial of gentamicin in surgical site infection (SSI) (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Surgical site infection, Hematoma and 4 more. Started Aug 2026; status: completed.
02
Drugs
gentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20260613069779N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260613069779N1.